The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 19,713 | 345,000 | SH | SOLE | 345,000 | 0 | 0 | ||
ACCOLADE INC | COM | 00437E102 | 3,403 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 6,255 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 2,221 | 43,000 | SH | SOLE | 43,000 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 2,466 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 1,108 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 2,118 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,648 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 3,105 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 5,384 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 629 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 14,572 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
AXONICS MODULATION TECHNOLOG | COM | 05465P101 | 2,396 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
BECTON DICKINSON & CO | COM | 075887109 | 4,863 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 4,068 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 3,927 | 52,000 | SH | SOLE | 52,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 11,425 | 117,500 | SH | SOLE | 117,500 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 3,157 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 9,587 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CERECOR INC | COM | 15671L109 | 1,812 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 10,144 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 7,942 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | ||
CVS HEALTH CORP | COM | 126650100 | 1,505 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 16,282 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
DANAHER CORPORATION | COM | 235851102 | 9,003 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
DENALI THERAPEUTICS INC | COM | 24823R105 | 5,539 | 97,000 | SH | SOLE | 97,000 | 0 | 0 | ||
ENVISTA HOLDINGS CORPORATION | COM | 29415F104 | 14,076 | 345,000 | SH | SOLE | 345,000 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 4,518 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 3,298 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
GLOBUS MED INC | CL A | 379577208 | 4,625 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 3,682 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 2,384 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 2,609 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 13,643 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 1,167 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 526 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 119 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 1,696 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 6,376 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
LHC GROUP INC | COM | 50187A107 | 10,517 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
LONGBOARD PHARMACEUTICALS IN | COM | 54300N103 | 491 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 5,574 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 770 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 9,752 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 5,907 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
MERCK & CO. INC | COM | 58933Y105 | 6,938 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,565 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
MISONIX INC | COM | 604871103 | 882 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
MYOVANT SCIENCES LTD | COM | G637AM102 | 1,338 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 4,271 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 3,554 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 5,580 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
PENNANT GROUP INC | COM | 70805E109 | 3,664 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
PERKINELMER INC | COM | 714046109 | 6,415 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 4,740 | 100,100 | SH | SOLE | 100,100 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 4,387 | 44,000 | SH | SOLE | 44,000 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 2,074 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 2,166 | 71,000 | SH | SOLE | 71,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 10,778 | 144,000 | SH | SOLE | 144,000 | 0 | 0 | ||
SHOCKWAVE MED INC | COM | 82489T104 | 1,303 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
SIGNIFY HEALTH INC | CL A COM | 82671G100 | 4,682 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
TELEFLEX INCORPORATED | COM | 879369106 | 4,986 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 2,600 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 375 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 1,139 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 3,008 | 14,000 | SH | SOLE | 14,000 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 6,004 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 1,736 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | 8,804 | 55,000 | SH | SOLE | 55,000 | 0 | 0 |